| 发明名称 |
ANTI-CD80 ANTIBODY HAVING ADCC ACTIVITY FOR ADCC MEDIATED KILLING OF B CELL LYMPHOMA CELLS ALONE OR IN COMBINATION WITH OTHER THERAPIES |
| 摘要 |
Methods for treating B cell malignancies, in particular B cell leukemia and lymphoma, using an anti-CD80 antibody alone or in combination with an anti-CD20 antibody or chemotherapy is provided. These methods result in a synergistic anti-tumor response. |
| 申请公布号 |
WO03039486(A2) |
申请公布日期 |
2003.05.15 |
| 申请号 |
WO2002US36226 |
申请日期 |
2002.11.12 |
| 申请人 |
IDEC PHARMACEUTICALS CORPORATION;HARIHARAN, KANDASAMY;HANNA, NABIL |
发明人 |
HARIHARAN, KANDASAMY;HANNA, NABIL |
| 分类号 |
A61K39/395;A61P35/00;A61P35/02;C07K16/28 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
